DCO
Decoy Therapeutics Inc. Common Stock (DCOY) Q1 2026 Annual Earnings
DCOY·Reported May 8, 2026·After market close
Diluted EPS came in at $-4.18 (+72.9% YoY), missed the $-4.12 consensus by $0.06.
Diluted EPS
$-4.18missed by $0.06
Consensus: $-4.12
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Decoy Therapeutics Inc. Common Stock's Q1 2026 earnings report.
Decoy Therapeutics Inc. Common Stock (DCOY) reported Q1 2026 earnings on May 8, 2026 after market close.
Decoy Therapeutics Inc. Common Stock reported diluted EPS of $-4.18 for Q1 2026.
EPS missed the consensus estimate of $-4.12 by $0.06.
Compared to the same quarter a year prior, diluted EPS grew 72.9% from $-15.44.
You can read the 10-K periodic report (0001193125-26-134897) directly on SEC EDGAR. The filing index links above go to sec.gov.